Valneva USA

Company snapshot

Valneva USA, Inc. Advancing vaccines for better lives.

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Valneva USA. Not investment advice.

• What is Valneva USA?

  Valneva Austria is a pharma organization headquartered in Wien, AT. Primary therapeutic focus areas include Encephalitis, Japanese Encephalitis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTria

• Is Valneva USA publicly traded?

  Valneva USA appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Valneva USA develop or market?

  We link 1 drug profile(s) where Valneva USA is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/valneva-austria-gmbh#company-drugs.

• What are the latest developments for Valneva USA?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Valneva USA focus on?

  Valneva USA focuses on Encephalitis, Japanese Encephalitis based on our analysis of their pipeline programs and drug development activities.